Managing common side effects of SSRIs

Journal of Psychosocial Nursing and Mental Health Services

Volumn 45, Issue 2, 2007, Pages 15-18

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947152587     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20070201-04     Document Type: Review

References (13)

1. Ashton, A.K., & Weinstein, W.L. (2002). Cyproheptadine for drug-induced sweating. American Journal of Psychiatry, 159, 874-875.
2. Bollini, P., Pampallona, S., Kupelnick, B., Tibaldi, G., & Munizza, C. (2006). Improving compliance in depression: A systematic review of narrative reviews. Journal of Clinical Pharmacy and Therapeutics, 31, 253-260.
3. Buecking, A., Vandeleur, C.L., Khazaal, Y., & Zullino, D.F. (2005). Mirtazapine in drug-induced excessive sweating. European Journal of Clinical Pharmacology, 61, 543-544.
4. Dording, C.M., Mischoulon, D., Petersen, T.J., Kornbluh, R., Gordon, J., Nierenberg, A.A., et al. (2002). The pharmacologic management of SSRI-induced side effects: A survey of psychiatrists. Annals of Clinical Psychiatry, 14, 143-147.
5. Finfgeld, D.L. (2004). Serotonin syndrome and the use of SSRIs. Journal of Psychosocial Nursing and Mental Health Services, 42(2), 16-20.
6. Fisher, S.E., & Vaughn-Cole, B. (2003). Similarities and differences in clients treated and in medications prescribed by APRNs and psychiatrists in a CMHC. Archives of Psychiatric Nursing, 17, 101-107.
7. Haddad, P. (1998). The SSRI discontinuation syndrome. Journal of Psychopharmacology, 12, 305-313.
8. Howland, R.H. (2005). Pharmacotherapy for insomnia. Journal of Psychosocial Nursing and Mental Health Services, 43(12), 13-16.
9. Masand, P.S., & Gupta, S. (1999). Selective serotonin-reuptake inhibitors: An update. Harvard Review of Psychiatry, 7, 69-84.
10. Perlis, R.H., Fava, M., Nierenberg, A.A., Pollack, M.H., Falk, W.E., Kienke, A.S., et al. (2002). Strategies for treatment of SSRI-associated sexual dysfunction: A survey of an academic psychopharmacology practice. Harvard Review of Psychiatry, 10, 109-114.
11. Rosenbaum, J.F., & Zajecka, J. (1997). Clinical management of antidepressant discontinuation. Journal of Clinical Psychiatry, 58(Suppl. 7), 37-40.
12. rd ed.). Philadelphia: Lippincott Williams & Wilkins.
13. Tepper, S.J., & Millson, D. (2003). Safety profile of the triptans. Expert Opinion on Drug Safety, 2, 123-132.